US 7501415
Selective inhibitors of ERK protein kinase and uses thereof
granted A61PA61P1/16A61P11/00
Quick answer
US patent 7501415 (Selective inhibitors of ERK protein kinase and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Mar 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P1/16, A61P11/00, A61P17/06, A61P25/00